Search Clinical Trials ?


Trials Open: 9
Cancer Type: Lymphoma
Protocol No.Title
16-HEM-08-ININCB050465 in relapsed or refractory DLBC
16-HEM-09/INCB18424-271Ruxolitinib + Corticosteroids for treatment of Steroid-Refractory aGVHD
16-MULTI-15-SIRovalpituzumab Tesirine for DLL3 Expressing Advanced Solid Tumors
MCC-16-GI-99Fosbretabulin with Everolimus in Neuroendocrine tumors with progression
MCC-16-MULTI-18Genomic Testing for Patients with Refractory Cancer to Determine Treatment
MCC-16-MULTI-19Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
NCI-CIRB-AHOD1331Brentuximab Vedotin for Newly diagnosed Classical Hodgkin Lymphoma
NCI-CIRB-LAO-11030-9930MEDI-570 for Relapsed/Refractory Peripheral T-Cell Lymphoma & Angioimmunoblastic T-Cell Lymphoma